Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / $0 Par Value Ordinary Shares
-
Shares outstanding
-
153M
-
Number of holders
-
86
-
Total shares
-
30.9M
-
Shares change
-
+425K
-
Total reported value, excl. options
-
$634M
-
Value change
-
+$1.15M
-
Put/Call ratio
-
1.45
-
Number of buys
-
41
-
Number of sells
-
-49
-
Price
-
$20.53
Significant Holders of Wave Life Sciences Ltd. - $0 Par Value Ordinary Shares (WVE) as of Q3 2019
89 filings reported holding WVE - Wave Life Sciences Ltd. - $0 Par Value Ordinary Shares as of Q3 2019.
Wave Life Sciences Ltd. - $0 Par Value Ordinary Shares (WVE) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.9M shares
of 153M outstanding shares and own 20.18% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7.78M shares), JANUS HENDERSON GROUP PLC (4.08M shares), Redmile Group, LLC (3.18M shares), WELLINGTON MANAGEMENT GROUP LLP (3.09M shares), BlackRock Inc. (1.84M shares), Bellevue Group AG (1.55M shares), BOXER CAPITAL, LLC (1M shares), ArrowMark Colorado Holdings LLC (988K shares), PRICE T ROWE ASSOCIATES INC /MD/ (878K shares), and PRIMECAP MANAGEMENT CO/CA/ (830K shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.